论文部分内容阅读
目的:探讨干眼症通过玻璃酸钠联合普拉洛芬治疗的效果。方法:研究对象来自我院2015年3月至2017年4月期间收治的100例干眼症患者,依据不同治疗分为对照组与观察组各50例,对照组运用玻璃酸钠滴眼液治疗,观察组运用玻璃酸钠滴眼液联合普拉洛芬滴眼液治疗,分析两组患者治疗后的各指标情况差异。结果:在治疗有效率上,观察组为96%,显著高于对照组78%,两组差异具有统计学意义(p<0.05);在干眼症评分与荧光素染色评分上,观察组各项治疗后降幅显著高于对照组,两组差异具有统计学意义(p<0.05);在泪液分泌试验与泪膜破裂时间上,观察组各项治疗后提升幅度显著高于对照组,两组差异具有统计学意义(p<0.05)。结论:干眼症通过玻璃酸钠联合普拉洛芬治疗可以有效的提升治疗疗效,改善相关疾病指数,适宜广泛推广。
Objective: To investigate the effect of dry eye treatment with sodium hyaluronate combined with pranoprofen. Methods: The subjects from our hospital from March 2015 to April 2017 were treated 100 cases of dry eye patients, divided into control group and observation group according to the different treatment of 50 cases, the control group treated with sodium hyaluronate eye drops , The observation group using sodium hyaluronate eye drops combined with pranoprofen eye drops treatment, analysis of two groups of patients after treatment indicators of differences. Results: In the treatment efficiency, the observation group was 96%, significantly higher than 78% in the control group, the difference between the two groups was statistically significant (p <0.05); in the dry eye score and the fluorescein staining score, the observation group (P <0.05). In tear secretion test and tear film rupture time, the improvement rate of the observation group after treatment was significantly higher than that of the control group, the two groups The difference was statistically significant (p <0.05). Conclusion: The combination of sodium hyaluronate and pranoprofen can effectively improve the therapeutic effect and improve the related disease index, which is suitable for wide spread.